What was the purchase price per share in the HR Form 4?

The reported purchase price was $16.46 per share for the 10,000 -share acquisition.

Healthcare Realty (HR) Director Purchase: 10,000 Shares at $16.46

Q: What did the Form 4 for Healthcare Realty (HR) disclose?

The Form 4 reports that director Thomas N. Bohjalian purchased 10,000 shares of HR at $16.46 per share on 08/13/2025 , raising his direct ownership to 75,520 shares.

Q: When was the transaction in the HR Form 4 executed?

The transaction date shown on the Form 4 is 08/13/2025 .

Q: Who reported the Form 4 transaction for HR?

The reporting person named on the Form 4 is Thomas N. Bohjalian , identified as a Director .

Filing Impact

(Moderate)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Director Thomas N. Bohjalian purchased 10,000 shares of Healthcare Realty Trust Inc (ticker HR) on 08/13/2025 at $16.46 per share. After the transaction his reported direct beneficial ownership is 75,520 shares. The purchase is disclosed on a Form 4 statement of changes in beneficial ownership.

Positive

Director Thomas N. Bohjalian acquired 10,000 shares, a clear insider purchase disclosed on Form 4
Direct beneficial ownership increased to 75,520 shares, providing updated transparency on insider holdings

Negative

None.

Insights

TL;DR: A director-reported purchase of 10,000 shares increases reported direct ownership to 75,520 shares.

The Form 4 shows a director-level insider, Thomas N. Bohjalian, executed a purchase (transaction code P) of 10,000 common shares at $16.46 per share on 08/13/2025. This is a routine disclosure required under Section 16 and updates the director's reported direct beneficial ownership to 75,520 shares. From a governance perspective, the filing meets disclosure obligations and provides transparency on insider holdings; there is no other governance detail or related-party context included in the document.

TL;DR: The insider purchase is a factual disclosure; the size appears modest and the filing alone is unlikely to be materially market-moving.

The Form 4 records a 10,000-share acquisition at $16.46, bringing direct ownership to 75,520 shares. The entry is clearly reported as a purchase and includes the transaction date. Absent additional context such as total outstanding shares or concurrent insider activity, this single transaction constitutes a routine insider purchase disclosure and does not on its own provide evidence of a material change to company fundamentals.

Insider Trade Summary

Net Buyer: 10,000 shares

Net Buy 1 txn

Insider Bohjalian Thomas N

Role Director

Bought 10,000 shs ($165K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	10,000	$16.46	$165K

Holdings After Transaction: Common Stock — 75,520 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 08/13/2025 - 05:01 PM

FAQ

What did the Form 4 for Healthcare Realty (HR) disclose?

The Form 4 reports that director Thomas N. Bohjalian purchased 10,000 shares of HR at $16.46 per share on 08/13/2025, raising his direct ownership to 75,520 shares.

How many shares does Thomas N. Bohjalian own after the reported transaction?

After the purchase reported on the Form 4, his direct beneficial ownership is 75,520 shares.

When was the transaction in the HR Form 4 executed?

The transaction date shown on the Form 4 is 08/13/2025.

Who reported the Form 4 transaction for HR?

The reporting person named on the Form 4 is Thomas N. Bohjalian, identified as a Director.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bohjalian Thomas N

(Last)

(First)

(Middle)

3310 WEST END AVENUE, SUITE 700

ATTENTION: ANDREW LOOPE

(Street)

NASHVILLE

37203

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Healthcare Realty Trust Inc [ HR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/13/2025		P		10,000	A	$16.46	75,520	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	/s/ Andrew E. Loope as power of attorney	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR